Michael Schiesel, DO

Keyphrases

1. AMSTAR 50%
2. Anticoagulation Reversal 12%
3. Bleeding Patients 12%
4. Blood Products 50%
5. Clearinghouse 16%
6. Clinical Practice Guidelines 75%
7. Clotting Factors 12%
8. Coagulation 12%
9. Confidence Interval 58%
10. Crystalloid 12%
11. Efficiency Increase 12%
12. Emergency Medicine 100%
13. Extracted Data 20%
14. Full-text Search 16%
15. Funding Agencies 29%
16. Funding Sources 33%
17. Governing Bodies 16%
18. Guideline Recommendations 66%
19. Guidelines International Network 16%
20. Hemorrhage Control 12%
21. Hospital Transfusion Committees 12%
22. Inclusion Criteria 54%
23. International Clinical Trials 12%
24. Largest Subset 16%
25. Major Bleed 12%
26. Major Bleeding 12%
27. Massive Transfusion 12%
28. Massive Transfusion Protocol 50%
29. Methodological Quality 50%
30. Mild Traumatic Brain Injury (mTBI) 50%
31. National Guidelines Clearinghouse 16%
32. National Organization 16%
33. Nonprofit Sector 16%
34. Point Order 12%
35. Point Scale 16%
36. PRISMA 33%
37. PRISMA Checklist 16%
38. Product Delivery 25%
39. Protocol Optimization 50%
40. Publication Bias 33%
41. Randomized Controlled Trial 50%
42. Rapid Delivery 12%
43. Registration Evaluation 16%
44. Reversal Agents 12%
45. Risk of Bias 16%
46. Search Strategy 16%
47. ST-elevation Myocardial Infarction (STEMI) 50%
48. Staff Training 12%
49. Strategy Study 16%
50. Subgroup Analysis 16%